Submitted by Anonymous (not verified) on 25 June 2026 - 8:29
Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Date of authorisation: 19/09/2022, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Date of authorisation: 19/09/2022, Revision: 14, Status: Authorised